Seaweed-derived Rhamnan Sulfate and Vascular Function

Completed · Not applicable · Has a placebo group

Conditions studied: Cardiovascular Diseases

In brief

The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.

Key facts

Study ID

NCT05651230

Run by

University of Texas at Austin

People needed

15

Starts

2023-04-01

Expected to finish

2025-02-01

Last updated by the study team

2026-06-09

Who can join

Age: 35 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• at least one risk factor for cardiovascular disease (e.g., dyslipidemia, hypertension, obesity, impaired fasting glucose)
• a BMI of <40 kg/m2

You may not qualify if…

• gastrointestinal disorders and/or renal disease
• pregnancy or lactation
• strenuous physical activity (>3 times/week)
• alcohol abuse

Where it is running

• Cardiovascular Aging Research Lab at UT Austin — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.